Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Larimar Therapeutics, Inc. (LRMR)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
16 Feb 2024
Flynn James E
Director, 10% Owner, * Director by Deputization
Larimar Therapeutics, Inc.
(LRMR)
6,151,389
+230%
4,290,617
$8.74
$37,499,990.00
BUY
14 Feb 2024
THOMAS FRANK E
Director
Larimar Therapeutics, Inc.
(LRMR)
2,000
+100%
2,000
$11.00
$22,000.00
BUY
17 May 2023
BEN-MAIMON CAROLE
President and CEO, Director, Officer
Larimar Therapeutics, Inc.
(LRMR)
266,829
+1%
5,000
$3.71
$18,525.00
BUY
17 May 2023
Truitt Joseph
Director
Larimar Therapeutics, Inc.
(LRMR)
2,750
+100%
2,750
$3.73
$10,257.50
BUY
17 May 2023
Celano Michael
Chief Financial Officer, Officer
Larimar Therapeutics, Inc.
(LRMR)
112,746
+4%
5,000
$3.73
$18,631.50
BUY
16 Sep 2022
Celano Michael
Chief Financial Officer, Officer
Larimar Therapeutics, Inc.
(LRMR)
31,746
+100%
31,746
$3.15
$99,999.91
BUY
16 Sep 2022
BEN-MAIMON CAROLE
President and CEO, Director, Officer
Larimar Therapeutics, Inc.
(LRMR)
56,829
+126%
31,746
$3.15
$99,999.91
BUY
16 Sep 2022
Hamilton Thomas Edward
Director
Larimar Therapeutics, Inc.
(LRMR)
507,590
+166%
317,460
$3.15
$999,999.00
BUY
16 Sep 2022
Flynn James E
Director, 10% Owner, * Director by Deputization
Larimar Therapeutics, Inc.
(LRMR)
4,721,183
+173%
11,111,108
$3.15
$34,999,990.00
BUY
30 Jun 2021
Hamilton Thomas Edward
Director
Larimar Therapeutics, Inc.
(LRMR)
190,130
+42%
56,710
$8.75
$496,212.50
BUY
30 Jun 2021
Flynn James E
Director, 10% Owner, * Director by Deputization
Larimar Therapeutics, Inc.
(LRMR)
1,943,406
+54%
685,710
$8.75
$5,999,962.50
SELL
28 Jun 2018
Hughes Thomas E.
See Remarks, Director, Officer
ZAFGEN, INC.
(ZFGN)
125,247
-2%
2,666.667
$120.00
$320,000.00
SELL
7 Mar 2018
Hughes Thomas E.
See Remarks, Director, Officer
ZAFGEN, INC.
(ZFGN)
157,247
-0%
416.667
$120.00
$50,000.00
BUY
13 Oct 2017
Heller Frances K
Director
ZAFGEN, INC.
(ZFGN)
47,961
+1%
833.333
$46.79
$38,988.00
BUY
11 Jul 2017
KIM DENNIS D
Chief Medical Officer, Officer
ZAFGEN, INC.
(ZFGN)
21,443
+4%
833.333
$40.68
$33,900.00
BUY
10 May 2017
KIM DENNIS D
Chief Medical Officer, Officer
ZAFGEN, INC.
(ZFGN)
11,443
+7%
833.333
$52.80
$44,000.00
BUY
19 Dec 2016
Heller Frances K
Director
ZAFGEN, INC.
(ZFGN)
30,000
+2%
833.333
$38.75
$32,290.00
BUY
15 Nov 2016
Heller Frances K
Director
ZAFGEN, INC.
(ZFGN)
20,000
+4%
833.333
$42.52
$35,434.00
BUY
29 Aug 2016
Hughes Thomas E.
President and CEO, Director, Officer
ZAFGEN, INC.
(ZFGN)
63,936
+1%
833.333
$35.98
$29,987.00
BUY
25 Jul 2016
Allen Patricia L
Chief Financial Officer, Officer
ZAFGEN, INC.
(ZFGN)
19,793
+7%
1,333.333
$37.40
$49,861.80
BUY
22 Jul 2016
Heller Frances K
Director
ZAFGEN, INC.
(ZFGN)
10,000
+9%
833.333
$35.88
$29,900.00
BUY
22 Jul 2016
Hughes Thomas E.
President and CEO, Director, Officer
ZAFGEN, INC.
(ZFGN)
53,936
+0%
416.667
$36.25
$15,104.00
SELL
20 Jul 2016
Flynn James E
10% Owner, Possible Member of 10% Group
ZAFGEN, INC.
(ZFGN)
247,413
-31%
111,791.586
$39.74
$4,442,776.50
BUY
12 Feb 2016
Flynn James E
10% Owner, Possible Member of 10% Group
ZAFGEN, INC.
(ZFGN)
441,043
+1%
5,378.75
$74.96
$403,186.80
BUY
9 Feb 2016
Flynn James E
10% Owner, Possible Member of 10% Group
ZAFGEN, INC.
(ZFGN)
418,747
+5%
22,291.084
$72.21
$1,609,667.80
Home